Blood cancers

Early data unpicks COVID-19 vaccine effectiveness in lymphoma patients

Patients who have been treated for some lymphomas can develop robust antibody responses to COVID-19 vaccination – at least once their treatment is completed, say UK researchers. But others may never achieve a vaccine response however long ago their treatment ended. In an interim analysis of the UK PROSECO study, data from 129 patients showed ...

Already a member?

Login to keep reading.

© 2021 the limbic